{"id":"W2904119070","doi":"10.1182/blood-2018-99-112125","title":"Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Population; Platelet; Immunosuppression; Clinical endpoint; Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; Von Willebrand factor; Exacerbation; Surgery; Immunology; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001774548,0.0003167873,0.000550387,0.00007041737,0.0004514256,0.00003202842,0.0003155648,0.00008353999,0.0001720601],"category_scores_gemma":[0.0001765355,0.0001719544,0.00003342131,0.0002616141,0.0008104196,0.0001388287,0.00021232,0.00013726,0.00004930216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004123331,"about_ca_system_score_gemma":0.00009120283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003451409,"about_ca_topic_score_gemma":0.0009755263,"domain_scores_codex":[0.998223,0.0002809743,0.0004702324,0.0005470983,0.0000876319,0.0003910355],"domain_scores_gemma":[0.998525,0.0004089469,0.0002349844,0.0006029418,0.0001954627,0.00003269542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2311525,0.1471829,0.2603204,0.0002131025,0.04005488,0.0003151778,0.1295902,0.00001099483,0.1064798,0.00068194,0.04553895,0.03845913],"study_design_scores_gemma":[0.6561386,0.02073132,0.2854266,0.001200029,0.001958949,0.00003611466,0.00763267,0.000006554646,0.02333752,0.00008358869,0.00248104,0.0009669916],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958886,0.001786209,0.000004804977,0.0001646527,0.0001755262,0.0012281,0.0005831317,0.00007381765,0.00009518794],"genre_scores_gemma":[0.9989519,0.00002307356,0.00004786125,0.00008318269,0.00004000002,0.00005679163,0.000681017,0.00002378471,0.00009242538],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4249861,"threshold_uncertainty_score":0.7012099,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02737733870102445,"score_gpt":0.2890959543500927,"score_spread":0.2617186156490682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}